|
PLRG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.617500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.262100E-03 |
| Normal-vs-Stage2 |
7.078200E-01 |
| Normal-vs-Stage3 |
1.256060E-03 |
| Normal-vs-Stage4 |
8.049200E-04 |
| Stage1-vs-Stage2 |
4.950100E-02 |
| Stage1-vs-Stage3 |
3.084600E-01 |
| Stage1-vs-Stage4 |
1.294770E-01 |
| Stage2-vs-Stage3 |
1.608240E-02 |
| Stage2-vs-Stage4 |
7.619900E-03 |
| Stage3-vs-Stage4 |
4.960600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.369160E-04 |
| Normal-vs-AfricanAmerican |
7.284100E-02 |
| Normal-vs-Asian |
1.917000E-03 |
| Caucasian-vs-AfricanAmerican |
6.331600E-01 |
| Caucasian-vs-Asian |
1.325560E-01 |
| AfricanAmerican-vs-Asian |
6.098800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.156390E-01 |
| Normal-vs-Female |
9.69600000000348E-05 |
| Male-vs-Female |
1.429030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.623450E-03 |
| Normal-vs-Age(41-60Yrs) |
7.233300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.458800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.027200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.988200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.845750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.344800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.615580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.222200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.652600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.428200E-04 |
| Classical-VS-Follicular |
5.88418203051333E-15 |
| Classical-VS-Other |
9.438200E-02 |
| Classical-VS-Normal |
8.77250000419494E-08 |
| Tall-VS-Follicular |
4.84057238736568E-14 |
| Tall-VS-Other |
1.599590E-03 |
| Tall-VS-Normal |
2.62320000166127E-08 |
| Follicular-VS-Other |
3.411800E-01 |
| Follicular-VS-Normal |
2.015400E-04 |
| Other-VS-Normal |
7.616400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.072000E-01 |
| Normal-vs-N1 |
8.897600E-03 |
| N0-vs-N1 |
1.883890E-02 |
|
|
